Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00390559 · ClinicalTrials.gov registry record · NA
Examining the Effect of the Nicotine Patch in Male and Female Smokers - 3
A NA study of Smoking Cessation and Drug Addiction, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT00390559: Completed NA study of Smoking Cessation and Drug Addiction, sponsored by Virginia Commonwealth University.
NCT00390559 is a NA study of Smoking Cessation and Drug Addiction that has completed, run by Virginia Commonwealth University. The registered enrollment target is 80 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00390559, a NA study of Smoking Cessation and Drug Addiction, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Treatment studies have demonstrated that current smoking cessation techniques are less effective for women. The purpose of this study is to determine the role that gender plays in the effectiveness of nicotine replacement therapy. In addition, the purpose of this study is to determine whether men and women differ in their response to smoking-related stimuli (e.g., taste or smell of a lit cigarette). Conclusions drawn from this study may help to improve cessation interventions for all smokers, particularly women.
Primary Outcome
The full scale name is the "Urge to smoke" visual analog scale (VAS). It measures self-reported "urge to smoke". As with any VAS a word or phrase (in this case, "Urge to Smoke" is centered over a horizontal line anchored on the left by "not at all" and on the right by "extremely." In this study, participants used a mouse to produce a vertical mark on the horizontal line, and the score was the distance of the mark from the left anchor expressed as a percentage of total line length. Thus, the mini
Conditions Studied
Interventions
- DRUG nicotine transdermal system
- DRUG Nicotine transdermal system
- OTHER Nicotine containing cigarette
- OTHER Placebo cigarette
Study Locations (1)
Virginia
- Virginia Commonwealth University - Clinical Behavioral Pharmacology Laboratory - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2005-10 |
| Est. Completion | 2008-03 |
| Phase | NA |
What the finished NCT00390559 record still lists
NCT00390559 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (83% lower).
The record links to 2 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 4 interventions - of which nicotine transdermal system is the first listed.
NCT00390559 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT00390559 about?
NCT00390559 is a clinical study titled "Examining the Effect of the Nicotine Patch in Male and Female Smokers - 3". Treatment studies have demonstrated that current smoking cessation techniques are less effective for women. The purpose of this study is to determine the role that gender plays in the effectiveness of nicotine replacement therapy. In addition, the purpose of this study is to determine whether men an...
What is the current status of trial NCT00390559?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2005-10. Estimated completion is 2008-03.
What conditions does trial NCT00390559 study?
This clinical trial studies the following conditions: Smoking Cessation, Drug Addiction.
What interventions are being tested in trial NCT00390559?
The interventions under investigation include: nicotine transdermal system (DRUG), Nicotine transdermal system (DRUG), Nicotine containing cigarette (OTHER), Placebo cigarette (OTHER).
Who is sponsoring clinical trial NCT00390559?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00390559 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00390559's enrollment target sits among peer trials
80 126th of 188 higher than 62 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia